# MBX Biosciences, Inc.: Form 8-K, filed Feb 5, 2026

- Company: [MBX Biosciences, Inc.](/companies/mbx.md) (CIK 1776111)
- Form: 8-K
- Filed: 2026-02-05
- Accepted by EDGAR: Feb 5, 2026, 16:27 ET
- Period: 2026-02-04
- Accession: 0001193125-26-039475
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1776111/000119312526039475/mbx-20260204.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776111/000119312526039475/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776111/000119312526039475/mbx-20260204.htm

Filed Feb 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-039475. Last ingested by Listed: Nov 12, 2026, 18:07 ET. No prices; not investment advice.
